Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
AbbVie (NY: ABBV)
78.28 USD  +0.98 (+1.27%)
Streaming Delayed Price  /  Updated: 10:42 AM EDT, Oct 22, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 1,651,641
Open 78.05
Bid (Size) 78.28 (3)
Ask (Size) 78.29 (2)
Prev. Close 77.30
Today's Range 77.75 - 78.66
52wk Range 62.66 - 94.98
Shares Outstanding 1,586,879,451
Dividend Yield 4.59%
Performance
YTD
-12.27%
-12.27%
1 Month
+7.34%
+7.34%
3 Month
+15.12%
+15.12%
6 Month
+0.17%
+0.17%
1 Year
-7.10%
-7.10%
Top News
More News
AbbVie Receives CHMP Positive Opinion for Upadacitinib (RINVOQ™) for the Treatment of Adults with Moderate to Severe Active Rheumatoid Arthritis
- CHMP positive opinion, supported by data from the pivotal Phase 3 SELECT rheumatoid arthritis program evaluating more than 4,400 patients, will now be referred to the European Commission for final... Read More
from PR Newswire
'Fast Money Halftime Report Traders' Weigh In On Twilio, Disney And More
On CNBC's "Fast Money Halftime Report," Joe Terranova said he doesn't want to buy Twilio Inc (NYSE: TWLO) at the ... Read More
category Benzinga , Fast Money Halftime Report , DIS , and 13 more.
from Benzinga
More News
Read More
Which High-Yield Dividend Aristocrat Is the Best Buy?
category ABBV , T , XOM , and 2 more.
from Motley Fool
Is TG Therapeutics a Buy?
category TGTX , Market News , ABBV
from Motley Fool
VTI, BRK.B, NEE, ABBV: Large Inflows Detected at ETF
category ETFs
from ETF Channel
3 Stocks With Fast-Growing Dividends That Retirees Will Love
category ABT , AGN , ABBV , and 6 more.
from Motley Fool
3 Companies to Watch At Kidney Week 2019
category RARX , RETA , Market News , and 3 more.
from Motley Fool
Dividend Stock Spotlight: International Business Machines (IBM)
category Technology , Stocks / Equities
from Blogs - TalkMarkets
Reata Pharmaceuticals Repositions Itself for Success
category RETA , Market News , SIVB , and 1 more.
from Motley Fool
Should Investors Buy AbbVie Right Now for Its Dividend?
category C , Market News , AGN , and 1 more.
from Motley Fool
Here's Why Reata Pharmaceuticals Skyrocketed Higher Today
category ABBV , RETA , Market News
from Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.